External Ear, Malignant External Otitis: Multimedia

References

1. Chandler JR. Malignant external otitis. Laryngoscope. Aug 1968;78(8):1257-94. [Medline].

2. Chandler JR. Malignant external otitis: further considerations. Ann Otol Rhinol Laryngol. Jul-Aug 1977;86(4 Pt 1):417-28. [Medline].

3. Franco-Vidal V, Blanchet H, Bebear C, Dutronc H, Darrouzet V. Necrotizing external otitis: a report of 46 cases. Otol Neurotol. Sep 2007;28(6):771-3. [Medline].

4. Soudry E, Joshua BZ, Sulkes J, Nageris BI. Characteristics and prognosis of malignant external otitis with facial paralysis. Arch Otolaryngol Head Neck Surg. Oct 2007;133(10):1002-4. [Medline].

5. Mani N, Sudhoff H, Rajagopal S, Moffat D, Axon PR. Cranial nerve involvement in malignant external otitis: implications for clinical outcome. Laryngoscope. May 2007;117(5):907-10. [Medline].

6. Peleg U, Perez R, Raveh D, Berelowitz D, Cohen D. Stratification for malignant external otitis. Otolaryngol Head Neck Surg. Aug 2007;137(2):301-5. [Medline].

7. Levenson MJ, Parisier SC, Dolitsky J, Bindra G. Ciprofloxacin: drug of choice in the treatment of malignant external otitis (MEO). Laryngoscope. Aug 1991;101(8):821-4. [Medline].

8. Benecke JE Jr. Management of osteomyelitis of the skull base. Laryngoscope. Dec 1989;99(12):1220-3. [Medline].

9. Davis JC, Gates GA, Lerner C, Davis MG Jr, Mader JT, Dinesman A. Adjuvant hyperbaric oxygen in malignant external otitis. Arch Otolaryngol Head Neck Surg. Jan 1992;118(1):89-93. [Medline].

10. Ling SS, Sader C. Fungal malignant otitis externa treated with hyperbaric oxygen. Int J Infect Dis. Sep 2008;12(5):550-2. [Medline].

11. Berenholz L, Katzenell U, Harell M. Evolving resistant pseudomonas to ciprofloxacin in malignant otitis externa. Laryngoscope. Sep 2002;112(9):1619-22. [Medline].

12. Rubin J, Yu VL, Stool SE. Malignant external otitis in children. J Pediatr. Dec 1988;113(6):965-70. [Medline].

13. Amorosa L, Modugno GC, Pirodda A. Malignant external otitis: review and personal experience. Acta Otolaryngol Suppl. 1996;521:3-16. [Medline].

14. Bae WK, Lee KS, Park JW, et al. A case of malignant otitis externa caused by Candida glabrata in a patient receiving haemodialysis. Scand J Infect Dis. 2007;39(4):370-2. [Medline].

15. Chandler JR. Malignant external otitis and osteomyelitis of the base of the skull. Am J Otol. Mar 1989;10(2):108-10. [Medline].

16. Chandler JR. Pathogenesis and treatment of facial paralysis due to malignant external otitis. Ann Otol Rhinol Laryngol. Oct 1972;81(5):648-58. [Medline].

17. Corey JP, Levandowski RA, Panwalker AP. Prognostic implications of therapy for necrotizing external otitis. Am J Otol. Jul 1985;6(4):353-8. [Medline].

18. Driscoll PV, Ramachandrula A, Drezner DA, Hicks TA, Schaffer SR. Characteristics of cerumen in diabetic patients: a key to understanding malignant external otitis?. Otolaryngol Head Neck Surg. Oct 1993;109(4):676-9. [Medline].

19. Epstein JS, Ganz WI, Lizak M, Grobman L, Goodwin WJ, Dewanjee MK. Indium 111-labeled leukocyte scintigraphy in evaluating head and neck infections. Ann Otol Rhinol Laryngol. Dec 1992;101(12):961-8. [Medline].

20. Gehanno P. Ciprofloxacin in the treatment of malignant external otitis. Chemotherapy. 1994;40 Suppl 1:35-40. [Medline].

21. Gherini SG, Brackmann DE, Bradley WG. Magnetic resonance imaging and computerized tomography in malignant external otitis. Laryngoscope. May 1986;96(5):542-8. [Medline].

22. Gold S, Som PM, Lucente FE, Lawson W, Mendelson M, Parisier SC. Radiographic findings in progressive necrotizing "malignant" external otitis. Laryngoscope. Mar 1984;94(3):363-6. [Medline].

23. Grandis JR, Curtin HD, Yu VL. Necrotizing (malignant) external otitis: prospective comparison of CT and MR imaging in diagnosis and follow-up. Radiology. Aug 1995;196(2):499-504. [Medline].

24. Johnson MP, Ramphal R. Malignant external otitis: report on therapy with ceftazidime and review of therapy and prognosis. Rev Infect Dis. Mar-Apr 1990;12(2):173-80. [Medline].

25. Kimmelman CP, Lucente FE. Use of ceftazidime for malignant external otitis. Ann Otol Rhinol Laryngol. Sep 1989;98(9):721-5. [Medline].

26. Lang R, Goshen S, Kitzes-Cohen R, Sadé J. Successful treatment of malignant external otitis with oral ciprofloxacin: report of experience with 23 patients. J Infect Dis. Mar 1990;161(3):537-40. [Medline].

27. Mendelson DS, Som PM, Mendelson MH, Parisier SC. Malignant external otitis: the role of computed tomography and radionuclides in evaluation. Radiology. Dec 1983;149(3):745-9. [Medline].

28. Meyers BR, Mendelson MH, Parisier SC, Hirschman SZ. Malignant external otitis. Comparison of monotherapy vs combination therapy. Arch Otolaryngol Head Neck Surg. Sep 1987;113(9):974-8. [Medline].

29. Nadol JB Jr. Histopathology of Pseudomonas osteomyelitis of the temporal bone starting as malignant external otitis. Am J Otolaryngol. Nov 1980;1(5):359-71. [Medline].

30. Okpala NC, Siraj QH, Nilssen E, Pringle M. Radiological and radionuclide investigation of malignant otitis externa. J Laryngol Otol. Jan 2005;119(1):71-5. [Medline].

31. Redleaf MI, Angeli SI, McCabe BF. Indium 111-labeled white blood cell scintigraphy as an unreliable indicator of malignant external otitis resolution. Ann Otol Rhinol Laryngol. Jun 1994;103(6):444-8. [Medline].

32. Ress BD, Luntz M, Telischi FF, Balkany TJ, Whiteman ML. Necrotizing external otitis in patients with AIDS. Laryngoscope. Apr 1997;107(4):456-60. [Medline].

33. Rubin Grandis J, Branstetter BF 4th, Yu VL. The changing face of malignant (necrotising) external otitis: clinical, radiological, and anatomic correlations. Lancet Infect Dis. Jan 2004;4(1):34-9. [Medline].

34. Rubin J, Yu VL. Malignant external otitis: insights into pathogenesis, clinical manifestations, diagnosis, and therapy. Am J Med. Sep 1988;85(3):391-8. [Medline].

35. Seabold JE, Simonson TM, Weber PC, et al. Cranial osteomyelitis: diagnosis and follow-up with In-111 white blood cell and Tc-99m methylene diphosphonate bone SPECT, CT, and MR imaging. Radiology. Sep 1995;196(3):779-88. [Medline].

36. Slattery WH 3rd, Brackmann DE. Skull base osteomyelitis. Malignant external otitis. Otolaryngol Clin North Am. Oct 1996;29(5):795-806. [Medline].

37. Stokkel MP, Boot CN, van Eck-Smit BL. SPECT gallium scintigraphy in malignant external otitis: initial staging and follow-up. Case reports. Laryngoscope. Mar 1996;106(3 Pt 1):338-40. [Medline].

38. Stokkel MP, Takes RP, van Eck-Smit BL, Baatenburg de Jong RJ. The value of quantitative gallium-67 single-photon emission tomography in the clinical management of malignant external otitis. Eur J Nucl Med. Nov 1997;24(11):1429-32. [Medline].

39. Strauss M, Aber RC, Conner GH, Baum S. Malignant external otitis: long-term (months) antimicrobial therapy. Laryngoscope. Apr 1982;92(4):397-406. [Medline].

40. Sudhoff H, Linthicum FH Jr. Malignant external otitis: temporal bone histopathology case of the month. Otol Neurotol. Mar 2003;24(2):346-7. [Medline].

41. Uri N, Gips S, Front A, Meyer SW, Hardoff R. Quantitative bone and 67Ga scintigraphy in the differentiation of necrotizing external otitis from severe external otitis. Arch Otolaryngol Head Neck Surg. Jun 1991;117(6):623-6. [Medline].

Further Reading

Keywords

malignant external otitis of the external ear, external ear, malignant external otitis, MEO, invasive external otitis, necrotizing external otitis, progressive external otitis, skull base osteomyelitis, ear infection, pseudomonal osteomyelitis of the temporal bone, Pseudomonas aeruginosa, P aeruginosa, diabetes, malignant external otitis

Contributor Information and Disclosures

Author

Brian Nussenbaum, MD, FACS, Associate Professor, Vice Chair for Clinical Affairs, Co-director of Fellowship in Microvascular Head/Neck Oncology, Department of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine
Brian Nussenbaum, MD, FACS is a member of the following medical societies: Alpha Omega Alpha, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Head and Neck Society, Phi Beta Kappa, Society of University Otolaryngologists-Head and Neck Surgeons, and Triological Society
Disclosure: Nothing to disclose.

Coauthor(s)

Peter S Roland, MD, Professor, Department of Neurological Surgery, Professor and Chairman, Department of Otolaryngology-Head and Neck Surgery, Director of Clinical Center for Auditory, Vestibular and Facial Nerve Disorders, Chief of Pediatric Otology, University of Texas Southwestern Medical Center; Adjunct Professor of Communicative Disorders, University of Texas School of Human Development
Peter S Roland, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Otolaryngic Allergy, American Academy of Otolaryngology-Head and Neck Surgery, American Auditory Society, American Laryngological Rhinological and Otological Society, American Neurotology Society, American Otological Society, North American Skull Base Society, and Society of University Otolaryngologists-Head and Neck Surgeons
Disclosure: Alcon labs Honoraria Speaking and teaching; GSK Honoraria Speaking and teaching; Advanced Bionics Honoraria Board membership; Cochlear corp Honoraria Board membership; Med El corp travel grants Consulting

Medical Editor

Jack A Shohet, MD, Associate Clinical Professor, Department of Otolaryngology-Head and Neck Surgery, University of California Irvine; Otolaryngologist, Shohet Ear Associates Medical Group, Inc
Jack A Shohet, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Medical Association, American Neurotology Society, American Tinnitus Association, and California Medical Association
Disclosure: Envoy Medical Consulting fee Consulting

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Gerard J Gianoli, MD, Clinical Associate Professor, Department of Otolaryngology-Head and Neck Surgery, Tulane University School of Medicine; Vice President, The Ear and Balance Institute; Chief Executive Officer, Ponchartrain Surgery Center
Gerard J Gianoli, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Neurotology Society, American Otological Society, Society of University Otolaryngologists-Head and Neck Surgeons, and Triological Society
Disclosure: Nothing to disclose.

CME Editor

Christopher L Slack, MD, Otolaryngology-Facial Plastic Surgery, Private Practice, Associated Coastal ENT; Medical Director, Treasure Coast Sleep Disorders
Christopher L Slack, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Medical Association
Disclosure: Nothing to disclose.

Chief Editor

Arlen D Meyers, MD, MBA, Professor, Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine
Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Head and Neck Society
Disclosure: Covidien Corp Consulting fee Consulting; US Tobacco Corporation unstricted gift unknown